Compare ONON & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONON | RGEN |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 11.0B |
| IPO Year | 2021 | 1995 |
| Metric | ONON | RGEN |
|---|---|---|
| Price | $35.00 | $175.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 31 | 20 |
| Target Price | $44.13 | ★ $203.21 |
| AVG Volume (30 Days) | ★ 9.8M | 1.2M |
| Earning Date | 11-10-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $16.59 | $14.98 |
| Revenue Next Year | $18.94 | $26.05 |
| P/E Ratio | $56.05 | ★ N/A |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $26.37 | $100.99 |
| 52 Week High | $51.08 | $198.87 |
| Indicator | ONON | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 48.23 |
| Support Level | $31.11 | $161.15 |
| Resistance Level | $38.73 | $188.59 |
| Average True Range (ATR) | 1.39 | 8.49 |
| MACD | 0.10 | -0.53 |
| Stochastic Oscillator | 46.94 | 38.56 |
Founded in Switzerland in 2010, sportswear firm On Holding generates more than 90% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of 2025 sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.